Elarex Inc
Elarex Inc, based in Burlington, ON, specializes in stabilizing biologicals, particularly vaccines, through a proprietary technology that combines viral vectors with optimized formulations and drying processes. Their innovative platform, PT120D, offers exceptional temperature stability, allowing vaccines typically requiring -80°C storage to be stored at -40°C, significantly enhancing their transportability and shelf life.
Founded in 2019 by Robert DeWitte and Carlos Filip, Elarex has evolved from research conducted at McMaster University, resulting in numerous publications and patents. The company's technology not only stabilizes vaccines but also benefits a wide array of biotherapeutics, including small molecules, enzymes, DNA, and RNA, positioning Elarex as a leader in the fight against infectious diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
